Skip to main navigation Skip to search Skip to main content

Evaluation of Fidaxomicin as a Potential Adjuvant Drug for Enhancing Temozolomide Cytotoxicity in Glioblastoma Therapy from Investigating Its Inhibitory Effects on Atp Binding Cassette Subfamily C Member (Abcc) 3-Mediated Gene/Lncrna Networks

Project: A - Government Institution › b - National Science and Technology Council

Project Details

StatusFinished
Effective start/end date8/1/20 → 7/1/21